Stocks and Investing Stocks and Investing
Wed, August 4, 2021

David Lebovitz Maintained (ALNY) at Buy with Increased Target to $234 on, Aug 4th, 2021


Published on 2024-10-27 17:29:23 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $224 to $234 on, Aug 4th, 2021.

David, nor any peers, have made any analyst calls on ALNY in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources